ZA859120B - Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer - Google Patents

Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer

Info

Publication number
ZA859120B
ZA859120B ZA859120A ZA859120A ZA859120B ZA 859120 B ZA859120 B ZA 859120B ZA 859120 A ZA859120 A ZA 859120A ZA 859120 A ZA859120 A ZA 859120A ZA 859120 B ZA859120 B ZA 859120B
Authority
ZA
South Africa
Prior art keywords
immunotoxin
containing polymer
mennose
drug
association
Prior art date
Application number
ZA859120A
Other languages
English (en)
Inventor
Pierre Casellas
Bernard Bourrie
Pierre Gros
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA859120B publication Critical patent/ZA859120B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA859120A 1984-11-29 1985-11-28 Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer ZA859120B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8418203A FR2573656B1 (fr) 1984-11-29 1984-11-29 Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose

Publications (1)

Publication Number Publication Date
ZA859120B true ZA859120B (en) 1986-08-27

Family

ID=9310066

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859120A ZA859120B (en) 1984-11-29 1985-11-28 Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer

Country Status (13)

Country Link
US (1) US4749566A (xx)
EP (1) EP0186551B1 (xx)
JP (1) JPH062679B2 (xx)
AT (1) ATE49708T1 (xx)
AU (1) AU588008B2 (xx)
CA (1) CA1254139A (xx)
DE (1) DE3575521D1 (xx)
DK (1) DK163030C (xx)
FR (1) FR2573656B1 (xx)
IE (1) IE58776B1 (xx)
IL (1) IL77168A0 (xx)
NZ (1) NZ214357A (xx)
ZA (1) ZA859120B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185434A (en) * 1985-02-13 1993-02-09 Sanofi Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units
EP0303681B1 (en) * 1987-02-24 1992-10-14 Xoma Corporation Immunosuppression in immunotoxin based human therapy
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
US5632990A (en) * 1988-04-22 1997-05-27 Cancer Research Campaign Tech. Ltd. Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
GB8809616D0 (en) * 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
US5112607A (en) * 1991-06-05 1992-05-12 The United States Of America As Represented By The Secretary Of The Army Potentiation of immunotoxin action by Brefeldin A
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
WO2006121803A1 (en) 2005-05-05 2006-11-16 Sensient Flavors Inc. Production of beta-glucans and mannans
JP6096111B2 (ja) 2010-05-10 2017-03-15 アセンド・バイオファーマシューティカルズ・リミテッド 免疫刺激組成物及びワクチン組成物
US20120177567A1 (en) * 2010-08-11 2012-07-12 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504010B1 (fr) * 1981-04-15 1985-10-25 Sanofi Sa Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
FR2521010B1 (fr) * 1982-02-09 1985-07-19 Sanofi Sa Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent
FR2522968B1 (fr) * 1982-03-10 1986-03-28 Sanofi Sa Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine
FR2536997B1 (fr) * 1982-03-11 1987-08-07 Sanofi Sa Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
FR2577135B1 (fr) * 1985-02-13 1989-12-15 Sanofi Sa Immunotoxines a longue duree d'action comportant un constituant glycopeptidique inactivant les ribosomes modifie sur ses motifs polysaccharidiques

Also Published As

Publication number Publication date
AU5047385A (en) 1986-06-05
EP0186551B1 (fr) 1990-01-24
FR2573656B1 (fr) 1987-02-27
IE852992L (en) 1986-05-29
US4749566A (en) 1988-06-07
DK554585A (da) 1986-05-30
AU588008B2 (en) 1989-09-07
DK554585D0 (da) 1985-11-29
NZ214357A (en) 1990-02-26
DK163030B (da) 1992-01-13
EP0186551A1 (fr) 1986-07-02
IL77168A0 (en) 1986-04-29
IE58776B1 (en) 1993-11-17
ATE49708T1 (de) 1990-02-15
JPH062679B2 (ja) 1994-01-12
CA1254139A (en) 1989-05-16
DE3575521D1 (de) 1990-03-01
DK163030C (da) 1992-06-15
FR2573656A1 (fr) 1986-05-30
JPS61197528A (ja) 1986-09-01

Similar Documents

Publication Publication Date Title
EP0647133A4 (en) COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY.
EG20380A (en) Enhanced skin penetration system for improved topical delivery of drugs
KR19980700975A (xx)
HU9401107D0 (en) Enhanced skin penetration system for improved topical delivery of drugs
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
FR2700167B1 (fr) Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
ZA859120B (en) Drug comprising an association of at least one immunotoxin and at least one mennose-containing polymer
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
EP0100363A4 (en) NITROIMIDAZOLE-BASED RADIO-SENSITIZERS AND THEIR PHARMACEUTICAL COMPOSITION.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
ZA88154B (en) Anti-inflammatory agents
EP0856315A4 (en) DRUG
FR2712289B1 (fr) Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
FR2721021B1 (fr) Nouveaux inhibiteurs de farnésyl transférase, leur préparation et les compositions pharmaceutique qui les contiennent.
WO1994020115A3 (en) Hyaluronic acid used as a cancer treatment
DE3363563D1 (en) Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
CA1263380C (en) MYCAMINOSYLTYLONOLIDE COMPOUNDS SUBSTITUTED FOR C-23 AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM
IT1280010B1 (it) Composizione farmaceutica a base di un complesso agente terapeutico/ matrice polimerica dotato di migliorate caratteristiche disapore
UA23872A (uk) Лікувальний препарат (його варіанти)
IT1201267B (it) Un agente che favorisce l'erezione e la fecondita' un metodo per produrre tale agente ad impiego dell'agente stesso nella produzione di composizioni che favoriscono l'erezione e la fecondita'